Viral Vector Market was worth USD 0.60 billion in 2022 and is estimated to grow at a CAGR of 19.7% in the forecasted period. The forecasted revenue hints at a growth of around 2.13 billion USD by 2029.
Corner Therapeutics Inc. raised $54 million in a series A financing to create vaccines to protect against cancer and infectious diseases by helping the immune system engineer T cells. The company’s core interest is in advancements in immunotherapy through direct manipulation of T cells, which are the “keys to the kingdom for any cancer therapy,” Nick Seaver, Corner’s chief business officer, told BioWorld.
Advanced Therapy Medicinal Products MarketThe European market for advanced therapy medicinal products is witnessing an unprecedented surge in growth, fueled by escalating demand for cutting-edge treatments and bolstered by supportive regulatory environments. Recent findings from a comprehensive market report reveal.
Advanced Therapy Medicinal Products MarketA recent analytical analysis by Future Market Insights estimates that the global Advanced Therapy Medicinal Products Market will generate US$ 8.7 billion in revenue by 2021. From 2022 to 2032, the market is projected to expand at a 15% CAGR, valued at US$ 39 billion. Tissue.
/PRNewswire/ According to a comprehensive research report by Brandessence Market Research (BMRC), "Viral Vector Manufacturing Market Size, Share Outlook.